Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer

Stopped drug combination not providing any efficacy. Will use this data in opening new trial

Conditions

• Ovarian Cancer
• Cancer of Ovary
• Cancer of the Ovary
• Ovary Neoplasms
• Primary Peritoneal Carcinoma

Interventions

• DRUG: Fenretinide/LXS + Ketoconazole

Sponsor

South Plains Oncology Consortium